SMITH PATRICK W — SEC insider filings

SEC reporting owner CIK 1167028. 59 insider filings on record with FilingPulse; latest filed 2026-11-20.

Transaction summary — filings shown

Covers the 50 most recent of 59 filings on record, filed 2021-09-09 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
AXON ENTERPRISE, INC. (AXON)CHIEF EXECUTIVE OFFICER, Director44—460 legs · 2,885,696 sh · $703,878,468120
Insight Molecular Diagnostics Inc. (IMDX)10% owner69 legs · 1,188,987 sh · $2,445,638—2

Insider filings — SMITH PATRICK W

FiledFormIssuerReported transactionsSource
2026-11-204Insight Molecular Diagnostics Inc. (IMDX)Other (J): 1,142,857 @ $1.75EDGAR
2026-09-104AXON ENTERPRISE, INC. (AXON)Sale (S): 71 @ $501.99 · Sale (S): 410 @ $503.74 · Sale (S): 1,104 @ $505.59 · Sale (S): 744 @ $506.48 · Sale (S): 749 @ $507.48 · Sale (S): 1,774 @ $508.45 · +5 moreEDGAR
2026-08-174AXON ENTERPRISE, INC. (AXON)Grant/award (A): 97,015 @ $0EDGAR
2026-08-114AXON ENTERPRISE, INC. (AXON)Sale (S): 193 @ $526.52 · Sale (S): 94 @ $527.95 · Sale (S): 207 @ $528.76 · Sale (S): 113 @ $530.36 · Sale (S): 223 @ $531.39 · Sale (S): 100 @ $532.51 · +24 moreEDGAR
2026-08-114AXON ENTERPRISE, INC. (AXON)Sale (S): 70 @ $566.62EDGAR
2026-07-094AXON ENTERPRISE, INC. (AXON)Sale (S): 82 @ $626.78 · Sale (S): 82 @ $628.20 · Sale (S): 41 @ $629.24 · Sale (S): 251 @ $631.35 · Sale (S): 123 @ $632.91 · Sale (S): 88 @ $634.16 · +20 moreEDGAR
2026-06-304AXON ENTERPRISE, INC. (AXON)Sale (S): 10,000 @ $500.00EDGAR
2026-06-084AXON ENTERPRISE, INC. (AXON)Sale (S): 20,000 @ $500EDGAR
2026-03-114AXON ENTERPRISE, INC. (AXON)Sale (S): 124 @ $546.81 · Sale (S): 969 @ $548.85 · Sale (S): 270 @ $549.86 · Sale (S): 676 @ $550.71 · Sale (S): 668 @ $551.84 · Sale (S): 175 @ $552.56 · +18 moreEDGAR
2026-02-264AXON ENTERPRISE, INC. (AXON)Sale (S): 10,000 @ $500.24EDGAR
2026-01-084AXON ENTERPRISE, INC. (AXON)Sale (S): 194 @ $610.25 · Sale (S): 791 @ $611.56 · Sale (S): 136 @ $612.39 · Sale (S): 572 @ $613.45 · Sale (S): 352 @ $614.65 · Sale (S): 204 @ $616.94 · +8 moreEDGAR
2025-12-094AXON ENTERPRISE, INC. (AXON)Sale (S): 294 @ $549.56 · Sale (S): 1,887 @ $550.68 · Sale (S): 4,522 @ $551.62 · Sale (S): 1,402 @ $552.42 · Sale (S): 1,121 @ $553.41 · Sale (S): 634 @ $554.38 · +1 moreEDGAR
2025-11-174AXON ENTERPRISE, INC. (AXON)Grant/award (A): 97,015 @ $0EDGAR
2025-11-124AXON ENTERPRISE, INC. (AXON)Sale (S): 681 @ $579.46 · Sale (S): 569 @ $580.40 · Sale (S): 422 @ $581.24 · Sale (S): 28 @ $582.64 · Sale (S): 428 @ $583.89 · Sale (S): 880 @ $585.04 · +20 moreEDGAR
2025-10-084AXON ENTERPRISE, INC. (AXON)Sale (S): 412 @ $706.75 · Sale (S): 643 @ $707.91 · Sale (S): 379 @ $709.15 · Sale (S): 1,124 @ $710.38 · Sale (S): 1,928 @ $711.40 · Sale (S): 1,529 @ $712.52 · +9 moreEDGAR
2025-09-094AXON ENTERPRISE, INC. (AXON)Sale (S): 283 @ $734.29 · Sale (S): 14 @ $735.95 · Sale (S): 1,353 @ $739.39 · Sale (S): 449 @ $740.62 · Sale (S): 1,403 @ $741.82 · Sale (S): 918 @ $742.95 · +7 moreEDGAR
2025-08-124AXON ENTERPRISE, INC. (AXON)Sale (S): 305 @ $821.68 · Sale (S): 969 @ $823.28 · Sale (S): 706 @ $824.54 · Sale (S): 92 @ $826.14 · Sale (S): 72 @ $827.40 · Sale (S): 456 @ $828.82 · +10 moreEDGAR
2025-04-234AXON ENTERPRISE, INC. (AXON)Sale (S): 875 @ $532.19 · Sale (S): 877 @ $533.22 · Sale (S): 1,289 @ $534.08 · Sale (S): 532 @ $534.87 · Sale (S): 62 @ $536.96 · Sale (S): 870 @ $537.91 · +13 moreEDGAR
2025-03-264AXON ENTERPRISE, INC. (AXON)Grant/award (A): 194,030 @ $0EDGAR
2025-02-114Oncocyte Corp (OCX)Purchase (P): 1,077,600 @ $2.05 · Other (J): 385,814 @ $2.05EDGAR
2025-02-044Oncocyte Corp (OCX)Purchase (P): 890 @ $2.01 · Purchase (P): 25 @ $2.02EDGAR
2025-01-314Oncocyte Corp (OCX)Purchase (P): 3,880 @ $2.01 · Purchase (P): 318 @ $2.01EDGAR
2025-01-154Oncocyte Corp (OCX)Purchase (P): 5,669 @ $2.08 · Purchase (P): 100 @ $2.08 · Purchase (P): 10,286 @ $2.15EDGAR
2024-12-274Oncocyte Corp (OCX)Purchase (P): 90,219 @ $2.13EDGAR
2024-12-174AXON ENTERPRISE, INC. (AXON)Gift (G): 29,531 @ $0 · Gift (G): 15,577 @ $0EDGAR
2024-10-044AXON ENTERPRISE, INC. (AXON)Sale (S): 605 @ $403.04 · Sale (S): 2,460 @ $403.94 · Sale (S): 1,404 @ $404.64 · Sale (S): 298 @ $405.70EDGAR
2024-10-024AXON ENTERPRISE, INC. (AXON)Option exercise (M): 10,118 @ $399.60 · Sale (S): 4,746 @ $400.02 · Option exercise (M): 100,917 @ $399.22 · Sale (S): 47,314 @ $400.07 · Option exercise (M): 58,965 @ $404.51 · Sale (S): 13,422 @ $400.07 · +9 moreEDGAR
2024-09-044AXON ENTERPRISE, INC. (AXON)Option exercise (M): 105,495 @ $364.97 · Sale (S): 1,308 @ $361.48 · Sale (S): 6,555 @ $362.20 · Sale (S): 9,530 @ $363.29 · Sale (S): 12,386 @ $364.24 · Sale (S): 20,221 @ $364.98 · +18 moreEDGAR
2024-08-274AXON ENTERPRISE, INC. (AXON)Option exercise (M): 170,000 @ $370.70 · Sale (S): 6,544 @ $370.35 · Sale (S): 42,529 @ $370.92 · Sale (S): 8,417 @ $372.08 · Sale (S): 12,308 @ $373.05 · Sale (S): 7,174 @ $374.03 · +24 moreEDGAR
2023-12-204AXON ENTERPRISE, INC. (AXON)Gift (G): 60,000 @ $0EDGAR
2023-05-304AXON ENTERPRISE, INC. (AXON)Grant/award (A): 530,488 (derivative) @ $0EDGAR
2023-05-224AXON ENTERPRISE, INC. (AXON)Grant/award (A): 10 @ $0 · Tax withholding (F): 4 @ $201.70EDGAR
2023-04-044AXON ENTERPRISE, INC. (AXON)Option exercise (M): 5,491 @ $227.39 · Sale (S): 1,439 @ $223.95 · Sale (S): 1,161 @ $224.87 · Option exercise (M): 5,491 (derivative) @ $0EDGAR
2023-03-314AXON ENTERPRISE, INC. (AXON)Option exercise (M): 116,135 @ $216.83 · Sale (S): 54,913 @ $217.28 · Sale (S): 13,728 @ $217.28 · Option exercise (M): 90,259 @ $217.70 · Sale (S): 20,963 @ $216.81 · Sale (S): 21,782 @ $217.66 · +16 moreEDGAR
2023-03-284AXON ENTERPRISE, INC. (AXON)Option exercise (M): 57,863 @ $218.59 · Sale (S): 5,408 @ $216.52 · Sale (S): 16,993 @ $217.55 · Sale (S): 5,019 @ $218.36 · Sale (S): 4,157 @ $218.36 · Sale (S): 2,270 @ $219.47 · +11 moreEDGAR
2023-03-134AXON ENTERPRISE, INC. (AXON)Grant/award (A): 5 @ $0 · Tax withholding (F): 2 @ $217.89EDGAR
2023-01-274AXON ENTERPRISE, INC. (AXON)Option exercise (M): 157,955 @ $192.18 · Sale (S): 4,803 @ $185.35 · Sale (S): 4,072 @ $186.22 · Sale (S): 10,026 @ $187.54 · Sale (S): 9,455 @ $188.73 · Sale (S): 18,833 @ $189.38 · +25 moreEDGAR
2023-01-244AXON ENTERPRISE, INC. (AXON)Option exercise (M): 52,261 @ $185.02 · Sale (S): 25,442 @ $185.24 · Sale (S): 6,360 @ $185.24 · Option exercise (M): 444,266 @ $188.95 · Sale (S): 214,732 @ $190.17 · Sale (S): 53,683 @ $190.17 · +11 moreEDGAR
2023-01-194AXON ENTERPRISE, INC. (AXON)Option exercise (M): 117,753 @ $184.47 · Sale (S): 54,057 @ $185.35 · Sale (S): 3,142 @ $186.47 · Sale (S): 5,638 @ $186.47 · Sale (S): 6,262 @ $187.47 · Sale (S): 2,400 @ $188.31 · +12 moreEDGAR
2021-12-024AXON ENTERPRISE, INC. (AXON)Option exercise (M): 13,233 @ $168.79 · Sale (S): 6,305 @ $180.30 · Sale (S): 1,576 @ $180.30 · Grant/award (A): 5 @ $0 · Tax withholding (F): 2 @ $159.36 · Option exercise (M): 13,233 (derivative) @ $0EDGAR
2021-11-294AXON ENTERPRISE, INC. (AXON)Option exercise (M): 56,619 @ $179.86 · Sale (S): 27,718 @ $180.05 · Sale (S): 6,930 @ $180.05 · Option exercise (M): 7,457 @ $177.20 · Sale (S): 3,628 @ $180.07 · Sale (S): 907 @ $180.07 · +6 moreEDGAR
2021-11-194AXON ENTERPRISE, INC. (AXON)Option exercise (M): 167 @ $172.89 · Sale (S): 20 @ $180 · Sale (S): 80 @ $180 · Option exercise (M): 11,982 @ $174.43 · Sale (S): 1,447 @ $180.16 · Sale (S): 5,790 @ $180.16 · +11 moreEDGAR
2021-11-174AXON ENTERPRISE, INC. (AXON)Option exercise (M): 1,067,255 @ $167.41 · Option exercise (M): 553,130 @ $177.79 · Sale (S): 65,990 @ $180.26 · Sale (S): 73,652 @ $180.26 · Sale (S): 35,854 @ $181.37 · Sale (S): 11,333 @ $182.33 · +26 moreEDGAR
2021-11-104AXON ENTERPRISE, INC. (AXON)Option exercise (M): 3,326 @ $176.65 · Sale (S): 403 @ $180.20 · Sale (S): 1,013 @ $180.20 · Sale (S): 400 @ $181.46 · Sale (S): 200 @ $182.11 · Option exercise (M): 330 @ $176.40 · +4 moreEDGAR
2021-11-054AXON ENTERPRISE, INC. (AXON)Option exercise (M): 81,765 @ $184.91 · Sale (S): 6,965 @ $181.78 · Sale (S): 15,446 @ $182.61 · Sale (S): 9,151 @ $183.65 · Sale (S): 8,474 @ $184.58 · Sale (S): 10,009 @ $184.58 · +15 moreEDGAR
2021-11-024AXON ENTERPRISE, INC. (AXON)Option exercise (M): 8,052 @ $179.96 · Sale (S): 985 @ $180.11 · Sale (S): 3,942 @ $180.11 · Option exercise (M): 85,234 @ $180.67 · Sale (S): 10,423 @ $180.47 · Sale (S): 26,652 @ $180.47 · +10 moreEDGAR
2021-10-264AXON ENTERPRISE, INC. (AXON)Option exercise (M): 62,716 @ $182.65 · Sale (S): 7,680 @ $180.48 · Sale (S): 337 @ $180.48 · Sale (S): 15,326 @ $181.38 · Sale (S): 11,830 @ $182.43 · Sale (S): 1,159 @ $183.18 · +18 moreEDGAR
2021-10-214AXON ENTERPRISE, INC. (AXON)Option exercise (M): 82,110 @ $185.27 · Sale (S): 2,700 @ $181.46 · Sale (S): 3,121 @ $182.45 · Sale (S): 6,946 @ $183.66 · Sale (S): 20,619 @ $184.64 · Sale (S): 6,716 @ $185.35 · +21 moreEDGAR
2021-10-184AXON ENTERPRISE, INC. (AXON)Option exercise (M): 7,046 @ $179.03 · Option exercise (M): 6,833 @ $177.94 · Sale (S): 3,330 @ $180.08 · Sale (S): 860 @ $180.19 · Sale (S): 832 @ $180.08 · Sale (S): 3,441 @ $180.19 · +8 moreEDGAR
2021-09-094AXON ENTERPRISE, INC. (AXON)Grant/award (A): 25 @ $0 · Tax withholding (F): 10 @ $181.15 · Grant/award (A): 2,652,440 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1167028 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs